Cargando…

Impact of plasma xanthine oxidoreductase activity in patients with heart failure with preserved ejection fraction

AIMS: Reactive oxygen species are reportedly involved in the mechanism underlying heart failure with preserved ejection fraction (HFpEF); however, the disease pathophysiology remains poorly understood. Xanthine oxidoreductase (XOR), the rate‐limiting enzyme of purine metabolism, plays an important r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Ken, Watanabe, Tetsu, Otaki, Yoichiro, Shishido, Tetsuro, Murase, Takayo, Nakamura, Takashi, Kato, Shigehiko, Tamura, Harutoshi, Nishiyama, Satoshi, Takahashi, Hiroki, Arimoto, Takanori, Watanabe, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373896/ https://www.ncbi.nlm.nih.gov/pubmed/32432414 http://dx.doi.org/10.1002/ehf2.12734

Ejemplares similares

Gender Differences in the Impact of Plasma Xanthine Oxidoreductase Activity on Coronary Artery Spasm
por: Watanabe, Ken, et al.
Publicado: (2021)

Endovascular Revascularization Improves the Central Hemodynamics and Augmentation Index in Patients with Peripheral Artery Disease
por: Watanabe, Ken, et al.
Publicado: (2019)

Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease
por: Otaki, Yoichiro, et al.
Publicado: (2023)

Impact of Iron Deficiency on Peripheral Artery Disease After Endovascular Therapy
por: Otaki, Yoichiro, et al.
Publicado: (2019)

Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Cardio-Renal Anemia Syndrome　― Difference in Prognostic Ability ―
por: Otaki, Yoichiro, et al.
Publicado: (2019)

Impact of Impaired Pancreatic β-Cell Function on Cardiovascular Prognosis in Heart Failure Patients Without Diabetes Mellitus
por: Narumi, Taro, et al.
Publicado: (2019)

Impact of Modified H(2)FPEF Score on Chronic Limb-Threatening Ischemia in Patients With Lower Extremity Artery Disease Who Underwent Endovascular Therapy
por: Shikama, Taku, et al.
Publicado: (2022)

Prognostic Impact of Renal Dysfunction at 1-Year Follow-Up on Clinical Outcomes After Percutaneous Coronary Intervention
por: Takahashi, Tetsuya, et al.
Publicado: (2023)

Effects of Nitric Oxide Synthase 3 Gene Polymorphisms on Cardiovascular Events in a General Japanese Population　― The Yamagata (Takahata) Study ―
por: Saito, Yuji, et al.
Publicado: (2022)

The association between microRNA-21 and hypertension-induced cardiac remodeling
por: Watanabe, Ken, et al.
Publicado: (2020)

Association of malnutrition with renal dysfunction and clinical outcome in patients with heart failure
por: Otaki, Yoichiro, et al.
Publicado: (2022)

Growth Differentiation Factor-15 and Clinical Outcomes in Japanese Patients With Ischemic Heart Disease
por: Kobayashi, Yuta, et al.
Publicado: (2023)

Intracardiac echocardiography–guided simultaneous pulmonary vein isolation and percutaneous transvenous mitral commissurotomy
por: Hashimoto, Naoto, et al.
Publicado: (2019)

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients
por: Fujimura, Yuki, et al.
Publicado: (2017)

Cardiac Nuclear High-Mobility Group Box 1 Ameliorates Pathological Cardiac Hypertrophy by Inhibiting DNA Damage Response
por: Takahashi, Tetsuya, et al.
Publicado: (2019)

The impact of physical activity on cardiovascular mortality in the general population
por: Takahashi, Tetsuya, et al.
Publicado: (2021)

Heart-type fatty acid binding protein and high-sensitivity troponin T are myocardial damage markers that could predict adverse clinical outcomes in patients with peripheral artery disease
por: Otaki, Yoichiro, et al.
Publicado: (2015)

The obesity paradox is not observed in chronic heart failure patients with metabolic syndrome
por: Narumi, Taro, et al.
Publicado: (2014)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Combined assessment of myocardial damage and electrical disturbance in chronic heart failure
por: Kadowaki, Shinpei, et al.
Publicado: (2017)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure
por: Narumi, Taro, et al.
Publicado: (2014)

Left atrial strain as evaluated by two-dimensional speckle tracking predicts left atrial appendage dysfunction in patients with acute ischemic stroke
por: Sasaki, Shintaro, et al.
Publicado: (2014)

Impact of Plasma Xanthine Oxidoreductase Activity on the Mechanisms of Distal Symmetric Polyneuropathy Development in Patients with Type 2 Diabetes
por: Fujishiro, Midori, et al.
Publicado: (2021)

Diurnal Variations in Serum Uric Acid, Xanthine, and Xanthine Oxidoreductase Activity in Male Patients with Coronary Artery Disease
por: Shimizu, Megumi, et al.
Publicado: (2023)

Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients
por: Nakatani, Ayumi, et al.
Publicado: (2017)

Plasma Xanthine Oxidoreductase (XOR) Activity in Cardiovascular Disease Outpatients
por: Matsushita, Masato, et al.
Publicado: (2020)

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry
por: Kurajoh, Masafumi, et al.
Publicado: (2023)

Independent links between plasma xanthine oxidoreductase activity and levels of adipokines
por: Furuhashi, Masato, et al.
Publicado: (2019)

Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin
por: Kinoshita, Daisuke, et al.
Publicado: (2020)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry
por: Yoshida, Shio, et al.
Publicado: (2020)

Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women
por: Kosaki, Keisei, et al.
Publicado: (2018)

Visualization of epicardial lead infection using (18)F‐FDG‐PET/CT imaging
por: Kurokawa, Tasuku, et al.
Publicado: (2021)

Relationship between Xanthine Oxidoreductase Redox and Oxidative Stress among Chronic Kidney Disease Patients
por: Terawaki, Hiroyuki, et al.
Publicado: (2018)

Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes
por: Okuyama, Tomoko, et al.
Publicado: (2021)

The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study
por: Otaki, Yoichiro, et al.
Publicado: (2016)

The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease
por: Goto, Jun, et al.
Publicado: (2021)

Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up
por: Yokoyama, Miyuki, et al.
Publicado: (2016)

Time‐dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure
por: Okazaki, Hirotake, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_357vh0ucqonfvfrmgoi94lk64s